Literature DB >> 30107491

Carbapenemases in New York City: the continued decline of KPC-producing Klebsiella pneumoniae, but a new threat emerges.

Alejandro Iregui1, Karen Ha1, Katharine Meleney1, David Landman1, John Quale1.   

Abstract

Objectives: Carbapenemase-producing Enterobacteriaceae are important nosocomial pathogens in many medical centres. Surveillance is needed to track trends and detect emergence of new carbapenemases.
Methods: Single-patient isolates of Enterobacteriaceae were gathered from seven medical centres in New York City over a 3 month period in 2017. Susceptibility testing was performed and isolates were screened for selected carbapenemases. Additional isolates referred to our laboratory in 2018 were also tested.
Results: KPC was found in 3/1911 (0.16%) isolates of Escherichia coli, 22/533 (4.1%) isolates of Klebsiella pneumoniae and 3/175 (1.7%) isolates of Enterobacter spp. Compared with prior surveillance studies performed over the past decade, there has been a persistent decline in the number of KPC-possessing K. pneumoniae. However, in 2018 two patients from the same skilled nursing facility admitted to two separate hospitals were found to harbour Enterobacteriaceae with NDM-5 and CTX-M-15. Conclusions: Since the height of the outbreak in 2006, there has been a decline in the number of KPC-possessing Enterobacteriaceae in New York City acute care medical centres. However continued vigilance is needed to detect the emergence of other carbapenemases.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30107491     DOI: 10.1093/jac/dky322

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Activity of Meropenem with a Novel Broader-Spectrum β-Lactamase Inhibitor, WCK 4234, against Gram-Negative Pathogens Endemic to New York City.

Authors:  Alejandro Iregui; Zeb Khan; David Landman; John Quale
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

2.  Aztreonam Combination Therapy: An Answer to Metallo-β-Lactamase-Producing Gram-Negative Bacteria?

Authors:  Ryan K Shields; Yohei Doi
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

3.  Activity of Cefiderocol Against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Endemic to Medical Centers in New York City.

Authors:  Alejandro Iregui; Zeb Khan; David Landman; John Quale
Journal:  Microb Drug Resist       Date:  2020-02-07       Impact factor: 3.431

4.  Quantitative Risk Assessment for the Introduction of Carbapenem-Resistant Enterobacteriaceae (CPE) into Dutch Livestock Farms.

Authors:  Natcha Dankittipong; Egil A J Fischer; Manon Swanenburg; Jaap A Wagenaar; Arjan J Stegeman; Clazien J de Vos
Journal:  Antibiotics (Basel)       Date:  2022-02-21

5.  New Delhi Metallo-β-Lactamase-5-Producing Escherichia coli in Companion Animals, United States.

Authors:  Stephen D Cole; Laura Peak; Gregory H Tyson; Renate Reimschuessel; Olgica Ceric; Shelley C Rankin
Journal:  Emerg Infect Dis       Date:  2020-02       Impact factor: 6.883

6.  Spread of ST348 Klebsiella pneumoniae Producing NDM-1 in a Peruvian Hospital.

Authors:  Maria J Pons; Marta Marí-Almirall; Barbara Ymaña; Jeel Moya-Salazar; Laura Muñoz; Sharon Sauñe; Richard Salazar-Hernández; Jordi Vila; Ignasi Roca
Journal:  Microorganisms       Date:  2020-09-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.